Copper in cancer: from limiting nutrient to therapeutic target

As an essential nutrient, copper’s redox properties are both beneficial and toxic to cells. Therefore, leveraging the characteristics of copper-dependent diseases or using copper toxicity to treat copper-sensitive diseases may offer new strategies for specific disease treatments. In particular, copp...

Full description

Bibliographic Details
Main Authors: Xiaolong Tang, Zaihua Yan, Yandong Miao, Wuhua Ha, Zheng Li, Lixia Yang, Denghai Mi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1209156/full
_version_ 1797796822134030336
author Xiaolong Tang
Xiaolong Tang
Zaihua Yan
Zaihua Yan
Yandong Miao
Wuhua Ha
Zheng Li
Lixia Yang
Denghai Mi
Denghai Mi
author_facet Xiaolong Tang
Xiaolong Tang
Zaihua Yan
Zaihua Yan
Yandong Miao
Wuhua Ha
Zheng Li
Lixia Yang
Denghai Mi
Denghai Mi
author_sort Xiaolong Tang
collection DOAJ
description As an essential nutrient, copper’s redox properties are both beneficial and toxic to cells. Therefore, leveraging the characteristics of copper-dependent diseases or using copper toxicity to treat copper-sensitive diseases may offer new strategies for specific disease treatments. In particular, copper concentration is typically higher in cancer cells, making copper a critical limiting nutrient for cancer cell growth and proliferation. Hence, intervening in copper metabolism specific to cancer cells may become a potential tumor treatment strategy, directly impacting tumor growth and metastasis. In this review, we discuss the metabolism of copper in the body and summarize research progress on the role of copper in promoting tumor cell growth or inducing programmed cell death in tumor cells. Additionally, we elucidate the role of copper-related drugs in cancer treatment, intending to provide new perspectives for cancer treatment.
first_indexed 2024-03-13T03:38:49Z
format Article
id doaj.art-c4b365a30cad4118bf0626614815ef5c
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-13T03:38:49Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-c4b365a30cad4118bf0626614815ef5c2023-06-23T13:31:20ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-06-011310.3389/fonc.2023.12091561209156Copper in cancer: from limiting nutrient to therapeutic targetXiaolong Tang0Xiaolong Tang1Zaihua Yan2Zaihua Yan3Yandong Miao4Wuhua Ha5Zheng Li6Lixia Yang7Denghai Mi8Denghai Mi9The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, ChinaThe Second Department of Gastrointestinal Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, ChinaThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, ChinaThe Second Department of Gastrointestinal Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, ChinaDepartment of Oncology, Yantai Affiliated Hospital of Binzhou Medical University, The Second Clinical Medical College of Binzhou Medical University, Yantai, Shandong, ChinaThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, ChinaDivision of Thoracic Tumor Multimodality Treatment and Department of Radiation Oncology, Cancer Center, West China Hospital of Sichuan University, Chengdu, Sichuan, ChinaGansu Academy of Traditional Chinese Medicine, Lanzhou, Gansu, ChinaThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, ChinaGansu Academy of Traditional Chinese Medicine, Lanzhou, Gansu, ChinaAs an essential nutrient, copper’s redox properties are both beneficial and toxic to cells. Therefore, leveraging the characteristics of copper-dependent diseases or using copper toxicity to treat copper-sensitive diseases may offer new strategies for specific disease treatments. In particular, copper concentration is typically higher in cancer cells, making copper a critical limiting nutrient for cancer cell growth and proliferation. Hence, intervening in copper metabolism specific to cancer cells may become a potential tumor treatment strategy, directly impacting tumor growth and metastasis. In this review, we discuss the metabolism of copper in the body and summarize research progress on the role of copper in promoting tumor cell growth or inducing programmed cell death in tumor cells. Additionally, we elucidate the role of copper-related drugs in cancer treatment, intending to provide new perspectives for cancer treatment.https://www.frontiersin.org/articles/10.3389/fonc.2023.1209156/fullcopper metabolismanticancerCu chelatorsCu ionophorespotential drugs
spellingShingle Xiaolong Tang
Xiaolong Tang
Zaihua Yan
Zaihua Yan
Yandong Miao
Wuhua Ha
Zheng Li
Lixia Yang
Denghai Mi
Denghai Mi
Copper in cancer: from limiting nutrient to therapeutic target
Frontiers in Oncology
copper metabolism
anticancer
Cu chelators
Cu ionophores
potential drugs
title Copper in cancer: from limiting nutrient to therapeutic target
title_full Copper in cancer: from limiting nutrient to therapeutic target
title_fullStr Copper in cancer: from limiting nutrient to therapeutic target
title_full_unstemmed Copper in cancer: from limiting nutrient to therapeutic target
title_short Copper in cancer: from limiting nutrient to therapeutic target
title_sort copper in cancer from limiting nutrient to therapeutic target
topic copper metabolism
anticancer
Cu chelators
Cu ionophores
potential drugs
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1209156/full
work_keys_str_mv AT xiaolongtang copperincancerfromlimitingnutrienttotherapeutictarget
AT xiaolongtang copperincancerfromlimitingnutrienttotherapeutictarget
AT zaihuayan copperincancerfromlimitingnutrienttotherapeutictarget
AT zaihuayan copperincancerfromlimitingnutrienttotherapeutictarget
AT yandongmiao copperincancerfromlimitingnutrienttotherapeutictarget
AT wuhuaha copperincancerfromlimitingnutrienttotherapeutictarget
AT zhengli copperincancerfromlimitingnutrienttotherapeutictarget
AT lixiayang copperincancerfromlimitingnutrienttotherapeutictarget
AT denghaimi copperincancerfromlimitingnutrienttotherapeutictarget
AT denghaimi copperincancerfromlimitingnutrienttotherapeutictarget